Improving Sunitinib Efficacy and tolerability in patients with metastatic clear cell carcinoma of the kidney by using a 14/7 day schedule and ToxicityAdjusted Dosing (ISE TAD147)

Project: Research

StatusFinished
Effective start/end date1/07/151/07/17